PubMed Health⌕ Search

PubMed · 10340643

Robin sequences and complexes: causal heterogeneity and pathogenetic/phenotypic variability.

Abstract

Robin sequence has been the subject of numerous general papers and has also been cited in specific syndrome articles. Evidence is provided that the condition is not only causally heterogeneous but also pathogenetically and phenotypically variable, necessitating the use of the terms "Robin sequences" and "Robin complexes."

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M M Cohen. 1999-06-04. Robin sequences and complexes: causal heterogeneity and pathogenetic/phenotypic variability.. https://pubmed.ncbi.nlm.nih.gov/10340643/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Heterogeneity of genetic alterations in prostate cancer: evidence of the complex nature of the disease.

Prostate cancer is a complex, multifactorial disease with genetic and environmental factors involved in its etiology. The search for genetic determinants involved in the disease has proven to be challenging, in part because such complex diseases are often not amenable to characterization by linkage analysis and positional cloning as is the case for diseases with simple Mendelian genetic inheritance. Prostate cancer susceptibility loci that have been reported so far include HPC1 (1q24-q25), PCAP (1q42-q43), HPCX (Xq27-q28), CAPB (1p36), HPC20 (20q13), HPC2/ELAC2 (17p11) and 16q23. Prostate cancer aggressiveness loci have also been reported (5q31-q33, 7q32 and 19q12). Further complicating the process is the existence of polymorphisms in several genes associated with prostate cancer including, AR, PSA, SRD5A2, VDR and CYP isoforms. These polymorphisms, however, are not thought to be highly penetrant alleles in families at high risk for prostate cancer. It is clear that prostate cancer etiology involves several genetic loci with no major gene accounting for a large proportion of susceptibility to the disease.

Genetic Heterogeneity↗

Nomenclature for describing the genetic characteristics of wild-type measles viruses (update).

Two areas of current research have the potential to improve the quality of virological surveillance of measles. A new highly sensitive cell line that does not secrete Epstein Barr virus is being tested as a replacement for B95a cells. Also, alternative protocols that simplify the logistics of specimen collection, such as dried blood spots, are being evaluated. A list of literature references about measles molecular epidemiology is available from WHO upon request. Periodic updates about the genetic characteristics of currently circulating strains and new genotypes will be published in the WHO Measles Bulletin and will be available via the Internet from the WHO strain bank at CDC.

Genetic Heterogeneity↗

The genetics of psoriasis 2001: the odyssey continues.

Accumulating evidence indicates that psoriasis is a multifactorial disorder caused by the concerted action of multiple disease genes in a single individual, triggered by environmental factors. Some of these genes control the severity of multiple diseases by regulating inflammation and immunity (severity genes), whereas others are unique to psoriasis. Various combinations of these genes can occur even within a single family, accounting in large measure for the many clinical manifestations of psoriasis. The disease-causing variants (alleles) of these genes probably arose early in the history of modern humans. As a result, psoriasis disease alleles are common in the general population, have a worldwide distribution, and often share the same ancestral chromosome with neutral alleles at adjacent loci. This phenomenon, called linkage disequilibrium, explains why psoriasis is strongly associated with HLA-Cw6 worldwide, although HLA-Cw6 is unlikely to be the disease allele. Many unaffected individuals carry 1 or more disease alleles, but lack other genetic and/or environmental factors necessary to produce disease. This explains why psoriasis develops in only about 10% of HLA-Cw6-positive individuals, and why genome-wide linkage scans for psoriasis and other multifactorial genetic disorders have not been uniformly successful. The Human Genome Project is rapidly generating a catalog of human DNA sequence variations. This resource has already allowed precise linkage disequilibrium mapping of the major histocompatibility complex psoriasis gene to just beyond HLA-C, toward HLA-A. This gene is likely to be identified soon. Further development and use of linkage disequilibrium resources will provide a powerful tool for the identification of the remaining psoriasis genes.

Genetic Heterogeneity↗